-
TTS Pharma is the first UK manufacturer to produce commercial cannabidiol free of illegal THC and CBN
Independent analysis reveals more illegal and unsafe products on the market Liverpool and London, UK, 19th September 2019 / Sciad Newswire / TTS Pharma Limited, a producer of the highest quality, legal and safe cannabinoids (including Cannabidiol (CBD)) for use in food, cosmetics and nutraceuticals, today announces the results of an independent analysis of its CBD oil. The…
-
Procarta receives carb-x award of up to $9.2 million
Stevenage, UK, 17th September 2019 / Sciad Newswire / Procarta Biosystems, a privately held UK-based biotech company, today announced a CARB-X award of up to $9.2 million to progress its pipeline of antibiotic precision medicines. The award includes initial non-dilutive funding up to $2.2 million with a further $7.0 million available if certain project milestones are met. The new antibiotics are…
-
Watson-Marlow Fluid Technology Group’s Flexicon PF7 pump technology shortlisted for PPMA Group Industry Awards
Falmouth, UK, 9th September 2019 / Sciad Newswire / The world leader in niche peristaltic and sinusoidal pumps and fluid path technologies,Watson-Marlow Fluid Technology Group, will present highlights from its broad range of positive displacement pumps and liquid filling technologies at the 2019 PPMA Total Show, exhibition stand D-90, including the Flexicon PF7, shortlisted for the PPMA Group Industry Awards. Flexicon Liquid…
-
PureWeld XL tubing stands up to technical challenges of continuous bioprocessing
Watson-Marlow Fluid Technology Group to present the results of a recent study on tubing peristaltic life and pumping performance at The Single Use Event Falmouth, UK, 3rdSeptember 2019 / A recent study from Watson-Marlow Fluid Technology Group (WMFTG), demonstrates that PureWeld XL tubingoffers extended lifespan and steady flow consistency when compared to other leading brands. Dr Chris Palmer, Tubing Product…
-
Amyndas Pharmaceuticals Initiates Phase 2a study of AMY-101 in adults with Periodontal inflammation and Gingivitis
28th August 2019 / Sciad Newswire / Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of novel complement therapeutics, announced today the launch of its Phase 2a clinical study, evaluating AMY-101 in adults with periodontal inflammation and gingivitis. AMY-101 is a novel synthetic cyclic peptide designed to inhibit the complement cascade centrally at the level of C3 (Complement component…
-
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics Research Triangle Park, N.C. (Aug. 13, 2019) – AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that…
-
New study highlights key characteristics of successful cell & gene therapy leaders
London, UK, 22nd July 2019 / Sciad Newswire / The RSA Group, the leading global Life Sciences executive search firm, has published the latest of its Talent Equity® Reports: Cell and Gene Therapy Report 2019. The new report looks at the cell and gene therapy (C&G) sector and the profile of leadership teams that are driving the most significant period of progress in…
-
How could digital therapeutics help the NHS?
Whether it be simple apps that provide users with mental health help or meditation, or long-term behaviour trackers and treatment optimisation software for patients with more serious conditions, the digital therapeutics market is set to grow larger and larger in the healthcare sector. Companies in this area aim to help patients digitally, withthe Digital Therapeutics…
-
Immunotherapy specialist benefits from Quantum bioprocessing pump
An immunotherapy specialist is leveraging the advantages of investing in a new Quantum bioprocessing pump from Watson-Marlow Fluid Technology Group (WMFTG). Seeking a higher capacity pump for its critical UF/DF (ultrafiltration/diafiltration) processes, the market-proven performance of Quantum for single-use downstream applications makes it the obvious choice. Capacity constraints “We were looking for a pump with more capacity…
-
How bioprinting is taking off in 2019
So far in 2019, we have seen bioprinting (the production of biomaterials that mimic the function of human tissue) surpass many major hurdles. It continues to move closer to developing solutions to transplant shortages by 3D printing using bio-inks, theoretically enabling the bioprinting of tissues and even full organs in the future. In May 2019,…